Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michele Klain

Showing results (61-70 of 80) with videos related to

Pageof 8
Sort By:
Current Oncology (Toronto, Ont.)|September 27, 2024
The Safety and Efficacy of Peptide Receptor Radionuclide Therapy for Gastro-Entero-Pancreatic Neuroendocrine Tumors: A Single Center ExperienceLeandra Piscopo, Emilia Zampella, Fabio Volpe, et al.
Radiology|December 25, 2009
Assessment of metabolic response to radioimmunotherapy with 90Y-ibritumomab tiuxetan in patients with relapsed or refractory B-cell non-Hodgkin lymphomaGiovanni Storto, Amalia De Renzo, Teresa Pellegrino, et al.
Journal of Clinical Medicine|January 26, 2024
Tumor Burden of Iodine-Avid Bone Metastatic Thyroid Cancer Identified via <sup>18</sup>F-Sodium Fluoride PET/CT ImagingCarmela Nappi, Emilia Zampella, Valeria Gaudieri, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 18, 2021
Ablation rate after radioactive iodine therapy in patients with differentiated thyroid cancer at intermediate or high risk of recurrence: a systematic review and a meta-analysisMichele Klain, Carmela Nappi, Emilia Zampella, et al.
Quantitative Imaging in Medicine and Surgery|February 3, 2021
Characterization with hybrid imaging of cystic pheochromocytomas: correlation with pathologyRoberta Galatola, Valeria Romeo, Chiara Simeoli, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|October 27, 2017
Added prognostic value of left ventricular shape by gated SPECT imaging in patients with suspected coronary artery disease and normal myocardial perfusionValeria Gaudieri, Carmela Nappi, Wanda Acampa, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 1, 2020
Comparison of simultaneous <sup>18</sup>F-2-[18F] FDG PET/MR and PET/CT in the follow-up of patients with differentiated thyroid cancerMichele Klain, Carmela Nappi, Emanuele Nicolai, et al.
Tomography (Ann Arbor, Mich.)|December 23, 2021
Qualitative Heterogeneous Signal Drop on Chemical Shift (CS) MR Imaging: Correlative Quantitative Analysis between CS Signal Intensity Index and Contrast Washout Parameters Using T1-Weighted SequencesArnaldo Stanzione, Francesco Verde, Roberta Galatola, et al.
Neuroendocrinology|June 25, 2020
Pancreatic Neuroendocrine Tumors in Patients with Multiple Endocrine Neoplasia Type 1: Diagnostic Value of Different MRI SequencesFrancesco Verde, Roberta Galatola, Valeria Romeo, et al.
Cancers|June 24, 2022
Prognostic Value of Hybrid PET/MR Imaging in Patients with Differentiated Thyroid CancerLeandra Piscopo, Carmela Nappi, Fabio Volpe, et al.
Pageof 8

Showing results (61-70 of 80) with videos related to

Sort By:
Pageof 8
Current Oncology (Toronto, Ont.)|September 27, 2024
The Safety and Efficacy of Peptide Receptor Radionuclide Therapy for Gastro-Entero-Pancreatic Neuroendocrine Tumors: A Single Center ExperienceLeandra Piscopo, Emilia Zampella, Fabio Volpe, et al.
Radiology|December 25, 2009
Assessment of metabolic response to radioimmunotherapy with 90Y-ibritumomab tiuxetan in patients with relapsed or refractory B-cell non-Hodgkin lymphomaGiovanni Storto, Amalia De Renzo, Teresa Pellegrino, et al.
Journal of Clinical Medicine|January 26, 2024
Tumor Burden of Iodine-Avid Bone Metastatic Thyroid Cancer Identified via <sup>18</sup>F-Sodium Fluoride PET/CT ImagingCarmela Nappi, Emilia Zampella, Valeria Gaudieri, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 18, 2021
Ablation rate after radioactive iodine therapy in patients with differentiated thyroid cancer at intermediate or high risk of recurrence: a systematic review and a meta-analysisMichele Klain, Carmela Nappi, Emilia Zampella, et al.
Quantitative Imaging in Medicine and Surgery|February 3, 2021
Characterization with hybrid imaging of cystic pheochromocytomas: correlation with pathologyRoberta Galatola, Valeria Romeo, Chiara Simeoli, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|October 27, 2017
Added prognostic value of left ventricular shape by gated SPECT imaging in patients with suspected coronary artery disease and normal myocardial perfusionValeria Gaudieri, Carmela Nappi, Wanda Acampa, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 1, 2020
Comparison of simultaneous <sup>18</sup>F-2-[18F] FDG PET/MR and PET/CT in the follow-up of patients with differentiated thyroid cancerMichele Klain, Carmela Nappi, Emanuele Nicolai, et al.
Tomography (Ann Arbor, Mich.)|December 23, 2021
Qualitative Heterogeneous Signal Drop on Chemical Shift (CS) MR Imaging: Correlative Quantitative Analysis between CS Signal Intensity Index and Contrast Washout Parameters Using T1-Weighted SequencesArnaldo Stanzione, Francesco Verde, Roberta Galatola, et al.
Neuroendocrinology|June 25, 2020
Pancreatic Neuroendocrine Tumors in Patients with Multiple Endocrine Neoplasia Type 1: Diagnostic Value of Different MRI SequencesFrancesco Verde, Roberta Galatola, Valeria Romeo, et al.
Cancers|June 24, 2022
Prognostic Value of Hybrid PET/MR Imaging in Patients with Differentiated Thyroid CancerLeandra Piscopo, Carmela Nappi, Fabio Volpe, et al.
Pageof 8